Byun Hyun Jeong, Jang Donghwi, Lee Jongeun, Oh Se Jin, Lim Youngkyoung, Park Ji-Hye, Lee Jong Hee, Lee Dong-Youn
Department of Dermatology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Ann Dermatol. 2021 Jun;33(3):278-280. doi: 10.5021/ad.2021.33.3.278. Epub 2021 May 4.
A capillary hemangioma is a vascular tumor with small capillary sized vascular channel. Multiple capillary hemangioma in relation with drugs have been rarely reported. Here in, we report a case of multiple capillary hemangioma in patient diagnosed with chronic myeloid leukemia who received tyrosine kinase inhibitors (TKIs). Histopathological findings have shown capillary proliferation in the upper dermis, which is consistent with capillary hemangioma. Since TKIs can paradoxically activate the MEK/ERK pathway which is required for angiogenesis, we presumed that the lesions as the cutaneous side effects of TKIs.
毛细血管瘤是一种具有小毛细血管大小血管通道的血管肿瘤。与药物相关的多发性毛细血管瘤鲜有报道。在此,我们报告一例诊断为慢性髓性白血病的患者在接受酪氨酸激酶抑制剂(TKIs)治疗后出现多发性毛细血管瘤的病例。组织病理学检查结果显示真皮上层有毛细血管增生,这与毛细血管瘤相符。由于TKIs可反常激活血管生成所需的MEK/ERK通路,我们推测这些病变是TKIs的皮肤副作用。